PCNA and lung adenocarcinoma: Another study considering the resected, early-stage lung adenocarcinoma analyzed PCNA as part of a prognostic phenotype and concluded that higher PCNA expression had statistically significant decreased 5-year overall survival (Lamort et al., 2022).